info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Renal Denervation Market Research Report Information, By Product (Simplicity, Vessix (V2), EnligHTN, Paradise, Iberis, and Others), By Technology (Radiofrequency, Ultrasound, Micro-infusion, and Others), By End-User (Hospital, Clinics, Ambulatory Surgery Centers, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/MED/5249-HCR | 115 Pages | Author: Kinjoll Dey| December 2024

Market Segmentation


Renal Denervation, Product Outlook (USD Billion, 2018-2032)




  • Simplicity




  • Vessix (V2)




  • EnligHTN




  • Paradise




  • Iberis




  • Others




Renal Denervation, Technology Outlook (USD Billion, 2018-2032)




  • Radiofrequency




  • Ultrasound




  • Micro-infusion




  • Others




Renal Denervation, End-users Outlook (USD Billion, 2018-2032)




  • Hospital




  • Clinics




  • Ambulatory surgery centers




  • Others




Renal Denervation Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • North America Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • North America Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • US Outlook (USD Billion, 2018-2032)




    • US Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • US Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • US Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • CANADA Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • CANADA Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Europe Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Europe Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Germany Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Germany Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • France Outlook (USD Billion, 2018-2032)




    • France Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • France Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • France Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • UK Outlook (USD Billion, 2018-2032)




    • UK Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • UK Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • UK Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • ITALY Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • ITALY Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Spain Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Spain Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • REST OF EUROPE Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • REST OF EUROPE Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Asia-Pacific Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Asia-Pacific Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • China Outlook (USD Billion, 2018-2032)




    • China Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • China Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • China Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Japan Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Japan Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • India Outlook (USD Billion, 2018-2032)




    • India Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • India Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • India Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Australia Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Australia Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Rest of Asia-Pacific Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Rest of Asia-Pacific Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Rest of the World Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Rest of the World Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Middle East Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Middle East Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Africa Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Africa Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Renal Denervation by Product




      • Simplicity




      • Vessix (V2)




      • EnligHTN




      • Paradise




      • Iberis




      • Others






    • Latin America Renal Denervation by Technology




      • Radiofrequency




      • Ultrasound




      • Micro-infusion




      • Others






    • Latin America Renal Denervation by End-users




      • Hospital




      • Clinics




      • Ambulatory surgery centers




      • Others







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Renal Denervation Market, by Product

6.1 Introduction

6.2 Symplicity

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

6.3 Vessix (V2)

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

6.3 EnligHTN

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

6.4 Paradise

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

6.5 Iberis

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

Market Estimates & Forecast country, 2020-2027

Chapter 7. Global Renal Denervation Market, By Technology

7.1 Introduction

7.2 Radiofrequency

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

7.3 Ultrasound

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

7.4 Micro-infusion

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

Chapter 8. Global Renal Denervation Market, by End-user Type

8.1 Introduction

8.2 Food Producing Animals

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

8.3 Companion Animals

Market Estimates & Forecast by region, 2020-2027

Market Estimates & Forecast country, 2020-2027

Chapter 9. Global Renal Denervation Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 The Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Boston Scientific

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Medtronic

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 ReCor Medical

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 St. Jude Medical

11.4.1 Company Overview

11.4.2 Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Cardiosonic

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Cordis

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Merial

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Kona Medical

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financial Overview

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Sound Intervention

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financial Overview

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Terumo Corporation

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financial Overview

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.12 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of the Renal Denervation Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Global Renal Denervation Market Synopsis, 2020-2027

Table 2 Global Renal Denervation Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Renal Denervation Market, by Region, 2020-2027, (USD Million)

Table 4 Global Renal Denervation Market, by Product, 2020-2027, (USD Million)

Table 5 Global Renal Denervation Market, By Technology, 2020-2027, (USD Million)

Table 6 Global Renal Denervation Market, by End-user type, 2020-2027, (USD Million)

Table 7 North America Global Renal Denervation Market, by Product, 2020-2027, (USD Million)

Table 8 North America Global Renal Denervation Market, by End-user type, 2020-2027,

(USD Million)

Table 9 North America Global Renal Denervation Market, By Technology, 2020-2027,

(USD Million)

Table 10 US Renal Denervation Market, by Product, 2020-2027, (USD Million)

Table 11 US Renal Denervation Market, by End-user type, 2020-2027, (USD Million)

Table 12 US Renal Denervation Market, By Technology, 2020-2027, (USD Million)

Table 13 Canada Renal Denervation Market,by Product, 2020-2027, (USD Million)

Table 14 Canada Renal Denervation Market,by End-user type, 2020-2027, (USD Million)

Table 15 Canada Renal Denervation Market, By Technology, 2020-2027, (USD Million)

Table 16 South America Renal Denervation Market, by Product, 2020-2027, (USD

Million)

Table 17 South America Renal Denervation Market, by End-user type, 2020-2027, (USD

Million)

Table 18 South America Renal Denervation Market, By Technology, 2020-2027, (USD

Million)

Table 19 Europe Renal Denervation Market, by Product, 2020-2027, (USD Million)

Table 20 Europe Renal Denervation Market, by End-user type, 2020-2027, (USD Million)

Table 21 Europe Renal Denervation Market, By Technology, 2020-2027, (USD Million)

Table 22 Western Europe Renal Denervation Market, by Product, 2020-2027, (USD

Million)

Table 23 Western Europe Renal Denervation Market, by End-user type, 2020-2027,

(USD Million)

Table 24 Western Europe Renal Denervation Market, By Technology, 2020-2027, (USD

Million)

Table 25 Eastern Europe Renal Denervation Market, by Product, 2020-2027, (USD

Million)

Table 26 Eastern Europe Renal Denervation Market, by End-user type, 2020-2027, (USD

Million)

Table 27 Eastern Europe Renal Denervation Market, By Technology, 2020-2027, (USD

Million)

Table 28 Asia Pacific Renal Denervation Market, by Product, 2020-2027, (USD

Million)

Table 29 Asia Pacific Renal Denervation Market, by End-user type, 2020-2027, (USD

Million)

Table 30 Asia Pacific Renal Denervation Market, By Technology, 2020-2027, (USD

Million)

Table 31 Middle East & Africa Renal Denervation Market, by Product, 2020-2027, (USD

Million)

Table 32 Middle East & Africa Renal Denervation Market, by End-user type, 2020-2027,

(USD Million)

Table 33 Middle East & Africa Renal Denervation Market, By Technology, 2020-2027,

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Renal Denervation Market

Figure 3 Segmentation Market Dynamics for Global Renal Denervation Market

Figure 4 Global Renal Denervation Market Share, by Product 2020

Figure 5 Global Renal Denervation Market Share, by End-user type 2020

Figure 6 Global Renal Denervation Market Share, By Technology, 2020

Figure 7 Global Renal Denervation Market Share, by Region, 2020

Figure 8 North America Renal Denervation Market Share, by Country, 2020

Figure 9 Europe Renal Denervation Market Share, by Country, 2020

Figure 10 Asia Pacific Renal Denervation Market Share, by Country, 2020

Figure 11 Middle East & Africa Renal Denervation Market Share, by Country, 2020

Figure 12 Global Renal Denervation Market: Company Share Analysis, 2020 (%)

Figure 13 Boston Scientific: Key Financials

Figure 14 Boston Scientific: Segmental Revenue

Figure 15 Boston Scientific: Geographical Revenue

Figure 16 Medtronic: Key Financials

Figure 17 Medtronic: Segmental Revenue

Figure 18 Medtronic: Geographical Revenue

Figure 19 ReCor Medical::Key Financials

Figure 20 ReCor Medical: Segmental Revenue

Figure 21 ReCor Medical: Geographical Revenue

Figure 22 St. Jude Medical: Key Financials

Figure 23 St. Jude Medical: Segmental Revenue

Figure 24 St. Jude Medical: Geographical Revenue

Figure 25 Cardiosonic:Key Financials

Figure 26 Cardiosonic: Segmental Revenue

Figure 27 Cardiosonic. Geographical Revenue

Figure 28 Lonza: Key Financials

Figure 29 Lonza: Segmental Revenue

Figure 30 Lonza: Geographical Revenue

Figure 31 Merial: Key Financials

Figure 32 Merial: Segmental Revenue

Figure 33 Merial: Geographical Revenue

Figure 35 Kona Medical: Segmental Revenue

Figure 36 Kona Medical: Geographical Revenue

Figure 37 Kona Medical: Key Financials

Figure 38 Sound Intervention: Segmental Revenue

Figure 39 Sound Intervention: Geographical Revenue

Figure 40 Sound Intervention: Key Financials

Figure 41 Terumo Corporation: Segmental Revenue

Figure 42 Terumo Corporation: Geographical Revenue

Figure 43 Terumo Corporation: Key Financials

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.